Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial (Q44222782)
Jump to navigation
Jump to search
scientific article published on 24 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial |
scientific article published on 24 May 2017 |
Statements
1 reference
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial (English)
1 reference
Pravin U Dugel
1 reference
Glenn J Jaffe
1 reference
Peter Sallstig
1 reference
James Warburton
1 reference
Andreas Weichselberger
1 reference
Mark Wieland
1 reference
Lawrence Singerman
1 reference
24 May 2017
1 reference
1 reference
124
1 reference
9
1 reference
1296-1304
1 reference
Identifiers
1 reference
1 reference